Legal & General Group
ALBO

Legal & General Group’s Albireo Pharma Inc ALBO Stock Holding History

Legal & General Group’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,990
Closed -$151K – 3410
2022
Q4 		$151K Buy
6,990
+434
+7% +$9.17K ﹤0.01% 2703
2022
Q3 		$127K Buy
6,556
+219
+3% +$4.53K ﹤0.01% 2756
2022
Q2 		$126K Buy
6,337
+218
+4% +$5.75K ﹤0.01% 2791
2022
Q1 		$183K Buy
6,119
+531
+10% +$15.5K ﹤0.01% 2705
2021
Q4 		$130K Hold
5,588
– – ﹤0.01% 2851
2021
Q3 		$175K Buy
5,588
+3,022
+118% +$93.5K ﹤0.01% 2729
2021
Q2 		$90K Sell
2,566
-266
-9% -$8.65K ﹤0.01% 2776
2021
Q1 		$100K Buy
2,832
+149
+6% +$5.5K ﹤0.01% 2620
2020
Q4 		$100K Buy
2,683
+1,193
+80% +$43.4K ﹤0.01% 2590
2020
Q3 		$50K Sell
1,490
-510
-26% -$14.9K ﹤0.01% 2699
2020
Q2 		$53K Sell
2,000
-61
-3% -$1.44K ﹤0.01% 2713
2020
Q1 		$34K Sell
2,061
-303
-13% -$6.66K ﹤0.01% 2732
2019
Q4 		$60K Buy
2,364
+421
+22% +$8.42K ﹤0.01% 2750
2019
Q3 		$39K Buy
1,943
+310
+19% +$8.03K ﹤0.01% 2846
2019
Q2 		$53K Hold
1,633
– – ﹤0.01% 2763
2019
Q1 		$53K Buy
1,633
+274
+20% +$7.38K ﹤0.01% 2697
2018
Q4 		$33K Hold
1,359
– – ﹤0.01% 2870
2018
Q3 		$45K Hold
1,359
– – ﹤0.01% 2828
2018
Q2 		$48K Buy
+1,359
New +$44K ﹤0.01% 2772

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Legal & General Group's ALBO Position: Q1 2023 in Review

Legal & General Group sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 6,990 shares — an estimated $151K sold.

Legal & General Group first reported a position in ALBO in Q2 2018 and held it in 19 quarters. The position peaked at $183K in Q1 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Legal & General Group reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Legal & General Group sold 6,990 Albireo Pharma Inc shares in Q1 2023, an estimated $151K.
  • Legal & General Group first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 19 quarters.
  • Legal & General Group's Albireo Pharma Inc position peaked at $183K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Legal & General Group's 13F filing for Q1 2023, filed 15 May 2023.